Literature DB >> 7777515

Chimeric tumor necrosis factor receptors with constitutive signaling activity.

F Bazzoni1, E Alejos, B Beutler.   

Abstract

Many hormone and cytokine receptors are crosslinked by their specific ligands, and multimerization is an essential step leading to the generation of a signal. In the case of the tumor necrosis factor (TNF) receptors (TNF-Rs), antibody-induced crosslinking is sufficient to trigger a cytolytic effect. However, the quaternary structural requirements for signaling--i.e., the formation of dimers, trimers, or higher-order multimers--have remained obscure. Moreover, it has not been clear whether the 55-kDa or 75-kDa TNF-R is responsible for initiation of cytolysis. We reasoned that an obligate receptor dimer, targeted to the plasma membrane, might continuously signal the presence of TNF despite the actual absence of the ligand. Such a molecule, inserted into an appropriate vector, could be used to project receptor-specific "TNF-like" activity to specific cells and tissues in vivo. Accordingly, we constructed sequences encoding chimeric receptors in which the extracellular domain of the mouse erythropoietin receptor (Epo-R) was fused to the "stem," transmembrane domain, and cytoplasmic domain of the two mouse TNF-Rs. Thus, the Epo-R group was used to drive dimerization of the TNF-R cytoplasmic domain. These chimeric proteins were well expressed in a variety of cell lines and bound erythropoietin at the cell surface. Both the 55-kDa and the 75-kDa Epo/TNF-R chimeras exerted a constitutive cytotoxic effect detected by cotransfection or clonogenic assay. Thus, despite the lack of structural homology between the cytoplasmic domains of the two TNF-Rs, a similar signaling endpoint was observed. Moreover, dimerization (rather than trimerization or higher-order multimerization) was sufficient for elicitation of a biological response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777515      PMCID: PMC41697          DOI: 10.1073/pnas.92.12.5376

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The erythropoietin receptor: dimerization, activation, and tumorigenesis.

Authors:  H F Lodish; D Hilton; G Longmore; S S Watowich; A Yoshimura
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1992

2.  Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects.

Authors:  M P Boldin; I L Mett; E E Varfolomeev; I Chumakov; Y Shemer-Avni; J H Camonis; D Wallach
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

3.  Induction of apoptosis by the low-affinity NGF receptor.

Authors:  S Rabizadeh; J Oh; L T Zhong; J Yang; C M Bitler; L L Butcher; D E Bredesen
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

4.  Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system.

Authors:  H Y Song; J D Dunbar; D B Donner
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

5.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein.

Authors:  M N Teng; K Turksen; C A Jacobs; E Fuchs; H Schreiber
Journal:  Clin Immunol Immunopathol       Date:  1993-11

7.  Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

Authors:  L A Tartaglia; D V Goeddel; C Reynolds; I S Figari; R F Weber; B M Fendly; M A Palladino
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

8.  Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.

Authors:  J Kolls; K Peppel; M Silva; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

Authors:  D W Banner; A D'Arcy; W Janes; R Gentz; H J Schoenfeld; C Broger; H Loetscher; W Lesslauer
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor.

Authors:  J Taverne; N Sheikh; J B de Souza; J H Playfair; L Probert; G Kollias
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

View more
  10 in total

Review 1.  Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.

Authors:  Sabine Adam-Klages; Dieter Adam; Ottmar Janssen; Dieter Kabelitz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95).

Authors:  B Z Stanger
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

3.  Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation.

Authors:  S A Rayner; W J King; R M Comer; J D Isaacs; G Hale; A J George; D F Larkin
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Structural and functional insights into RAGE activation by multimeric S100B.

Authors:  Thorsten Ostendorp; Estelle Leclerc; Arnaud Galichet; Michael Koch; Nina Demling; Bernd Weigle; Claus W Heizmann; Peter M H Kroneck; Günter Fritz
Journal:  EMBO J       Date:  2007-07-26       Impact factor: 11.598

5.  The -383A>C TNFRI polymorphism is associated with soluble levels and clinical activity in rheumatoid arthritis.

Authors:  Y Valle; J R Padilla-Gutiérrez; N M Torres-Carrillo; I Y Ledezma-Lozano; E G Corona-Sánchez; M Vázquez-Del Mercado; H Rangel-Villalobos; J I Gámez-Nava; L González-López; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2009-07-07       Impact factor: 2.631

6.  TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.

Authors:  S Y Lee; S Y Lee; Y Choi
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

7.  Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.

Authors:  V Vandevoorde; G Haegeman; W Fiers
Journal:  J Cell Biol       Date:  1997-06-30       Impact factor: 10.539

8.  Structural basis for ligand-mediated mouse GITR activation.

Authors:  Zhaocai Zhou; Yukiko Tone; Xiaomin Song; Keiji Furuuchi; James D Lear; Herman Waldmann; Masahide Tone; Mark I Greene; Ramachandran Murali
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

9.  Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics.

Authors:  Jenny Hu; Yanbin Yu; Hong Han; Francesca Civoli; Yao Zhuang; John Thomas; Steve Swanson; Shuqian Jing; Shalini Gupta
Journal:  Cells       Date:  2014-02-10       Impact factor: 6.600

10.  Effect of gene transfer of tumor necrosis factor receptors into human lung carcinoma cell line.

Authors:  H Ohara; Y Hasegawa; T Kawabe; S Ichiyama; T Hara; Y Shimono; H Saito; K Shimokata
Journal:  Jpn J Cancer Res       Date:  1998-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.